CAPOX VERSUS MFOLFOX AS ADJUVANT CHEMOTHERAPY IN PATIENTS WITH STAGE 3 COLON CANCER: A COST-EFFECTIVENESS STUDY

被引：0
|
作者：
Abuloha, S. [1 ]
Li, P. [1 ]
Bian, J. [1 ]
Guo, Y. [1 ]
Shao, H. [1 ]
机构：
[1] Univ Florida, Gainesville, FL USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE189
引用
收藏
页码：S370 / S370
页数：1
相关论文
共 50 条
  • [1] Cost-Effectiveness of Adjuvant Chemotherapy in the Treatment of Early-Stage Colon Cancer
    Soni, Amy
    Chu, Edward
    CLINICAL COLORECTAL CANCER, 2015, 14 (04) : 219 - 226
  • [2] COST-EFFECTIVENESS ANALYSIS OF OXLIPLATIN IN ADJUVANT THERAPY FOR STAGE 3 COLON CANCER PATIENTS IN JAPAN
    Fukuda, T.
    Shiroiwa, T.
    Takeuchi, T.
    Shimozuma, K.
    Ohashi, Y.
    VALUE IN HEALTH, 2010, 13 (07) : A266 - A266
  • [3] Adjuvant chemotherapy in patients with resectable stage III colon cancer: lifetime cost-effectiveness and cost-utility analysis
    Bonistalli, L
    Bardelli, F
    Costantini, M
    Trallori, G
    d'Albasio, G
    Messori, A
    CANCER JOURNAL - FRANCE, 1998, 11 (01): : 39 - 47
  • [4] Cost-Effectiveness of Adjuvant FOLFOX and 5FU/LV Chemotherapy for Patients with Stage II Colon Cancer
    Ayvaci, Mehmet U. S.
    Shi, Jinghua
    Alagoz, Oguzhan
    Lubner, Sam J.
    MEDICAL DECISION MAKING, 2013, 33 (04) : 521 - 532
  • [5] Cost-effectiveness of adjuvant chemotherapy in early stage breast cancer
    John, Preethi
    Bannuru, Raveendhara R.
    Cohen, Joshua T.
    Buchsbaum, Rachel J.
    Erban, John Kalil
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] Cost-effectiveness of 12 months of capecitabine as adjuvant chemotherapy for stage III colon cancer: preplanned cost-effectiveness analysis of the JFMC37-0801 study
    Shibahara, Hidetoshi
    Shiroiwa, Takeru
    Ishiguro, Megumi
    Nakamura, Masato
    Hasegawa, Junichi
    Yamaguchi, Shigeki
    Masuda, Yuriko
    Sakamoto, Junichi
    Tomita, Naohiro
    Fukuda, Takashi
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2022, 23 (07): : 1159 - 1171
  • [7] Modeling the Cost-Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer in South African Public Hospitals
    Pumpalova, Yoanna
    Rogers, Alexandra M.
    Tan, Sarah Xinhui
    Herbst, Candice-lee
    Ruff, Paul
    Neugut, Alfred I.
    Hur, Chin
    JCO GLOBAL ONCOLOGY, 2021, 7 : 1730 - 1741
  • [8] Cost-effectiveness of 12 months of capecitabine as adjuvant chemotherapy for stage III colon cancer: preplanned cost-effectiveness analysis of the JFMC37-0801 study
    Hidetoshi Shibahara
    Takeru Shiroiwa
    Megumi Ishiguro
    Masato Nakamura
    Junichi Hasegawa
    Shigeki Yamaguchi
    Yuriko Masuda
    Junichi Sakamoto
    Naohiro Tomita
    Takashi Fukuda
    The European Journal of Health Economics, 2022, 23 : 1159 - 1171
  • [9] Cost-effectiveness of adjuvant chemotherapy for patients with high-risk stage II and stage III colon cancer in South Africa.
    Pumpalova, Yoanna S.
    Rogers, Alexandra M.
    Tan, Sarah Xinhui
    Herbst, Candice-Lee
    Ruff, Paul
    Neugut, Alfred I.
    Hur, Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [10] Comparison of Hematological Toxicity of mFOLFOX6 vs CAPOX Chemotherapy Regimens in Adjuvant Treatment of Stage II-III Colon Cancer Patients
    Harutyunyan, Lilit
    Arakelyan, Jemma
    Safaryan, Liana
    Avagyan, Armen
    Zohrabyan, Davit
    Sargsyan, Lilit
    Hakobyan, Lusine
    Iskanyan, Samvel
    Papyan, Ruzanna
    Harutyunyan, Martin
    Mkrtchyan, Gohar
    Rushanyan, Marine
    Tamamyan, Gevorg
    Danielyan, Samvel
    Jilavyan, Aram
    Tananyan, Armen
    Bardakhchyan, Samvel
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S268 - S268
12345